ESR1 and breast carcinoma: In the research setting, MxIF has also been applied to evaluate signaling pathway changes in mouse salivary glands,26 estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki67 colocalization in breast cancer,27 and other single‐cell analyses.28, 29